DelveInsight Business Research, a Business Consultant and Knowledge Partner, Started Operations in Delhi
Summary
With the combined expertise of researchers, market analysts and consultants, DelveInsight provide high-quality, accurate and transparent industry insight that helps clients to achieve growth and increase business value.DelveInsight combines industry expertise with innovation by collecting, analyzing and communicating to deliver critical information to leading decision makers in the Approved drugs market, Active Pharmaceutical (API) market, Generic market and Drug’s research and development helping Drug developing companies, Generics and API manufacturing companies to strategize and identify the right thrust areas and potential customers for their existing and new products.New Delhi, India, July 06, 2014 --( PR.com )-- DelveInsight Business Research, a start up market research and business consulting firm has started their office in Delhi.DelveInsight is the premier source of actionable insights into healthcare industries across US, Europe, India, China and all emerging markets.With the combined expertise of researchers, market analysts and consultants, DelveInsight provide high-quality, accurate and transparent industry insight that helps clients to achieve growth and increase business value.“Our growing reputation as a provider of leading industry research and consulting has attracted the business of some of the leading corporations in the world, who we have helped with expanding services in emerging markets,” said Dr. B.K.Agrawal, Managing Partner, DelveInsight.DelveInsight combines industry expertise with innovation by collecting, analyzing and communicating to deliver critical information to leading decision makers in the Approved drugs market, Active Pharmaceutical (API) market, Generic market and Drug’s research and development helping Drug developing companies, Generics and API manufacturing companies to strategize and identify the right thrust areas and potential customers for their existing and new products.